Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PREP | P48147 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24024276 | 1.00 | CHRM2 (0.44) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL23926142 | 0.89 | CHRM2 (0.38) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL9310931 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL9310923 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL19189558 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL583949 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL24540373 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL9311613 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL16042463 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP | |
| SCHEMBL31080064 | 0.85 | CHRM2 (0.46) | CHRM2CHRM1CHRM3HSD17B10PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023034290-A1 | NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF KRAS | INCYTE CORPORATION (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023283213-A1 | TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS | INCYTE CORPORATION (US) | 2023-01-12 | — | — | WO | disclosed |
| WO-2021211864-A1 | FUSED TRICYCLIC KRAS INHIBITORS | INCYTE CORPORATION (US) | 2021-10-21 | — | — | WO | disclosed |